Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Mice, Nude"" wg kryterium: Temat


Tytuł:
Identification and validation of KIF23 as a hypoxia-regulated lactate metabolism-related oncogene in uterine corpus endometrial carcinoma.
Autorzy:
Wang T; The Gynecology Department, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Peng X; The Gynecology Department, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Liu W; The Gynecology Department, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Ji M; The Gynecology Department, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Sun J; The Gynecology Department, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2024 Mar 15; Vol. 341, pp. 122490. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Oncogenes*/genetics
Endometrial Neoplasms*/genetics
Animals ; Mice ; Humans ; Female ; Mice, Nude ; Mutation ; Hypoxia ; Tumor Microenvironment/genetics ; Microtubule-Associated Proteins
Czasopismo naukowe
Tytuł:
Design, Synthesis, and Bioevaluation of Novel Reversibly Photoswitchable PI3K Inhibitors Based on Phenylazopyridine Derivatives toward Light-Controlled Cancer Treatment.
Autorzy:
Zhang Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Deng J; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Tian H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Qi H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Xiong T; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Lin S; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Dong Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Luo L; Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Wu D; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Zhang K; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Ji M; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Du T; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Sheng L; Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Chen X; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Xu H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.; CAMS Key Laboratory of Small Molecule Immuno-Oncology Drug Discovery, Chinese Academy of Medical Sciences, Beijing 100050, China.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2024 Mar 14; Vol. 67 (5), pp. 3504-3519. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Neoplasms*
Humans ; Animals ; Mice ; Phosphatidylinositol 3-Kinases/metabolism ; Molecular Docking Simulation ; Mice, Nude ; Zebrafish/metabolism ; Phosphoinositide-3 Kinase Inhibitors/pharmacology ; Structure-Activity Relationship ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model.
Autorzy:
Guo R; Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Middle Zhi-jiang Road, Shanghai, 200071, People's Republic of China.
Lu F; Department of Radiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Lin J; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, People's Republic of China.
Fu C; MR Application Development, Siemens Shenzhen Magnetic Resonance Ltd, Shenzhen, 518057, People's Republic of China.
Liu M; MR scientific Marketing, Diagnostic Imaging, Siemens Healthineers Ltd, Shanghai, 201318, People's Republic of China.
Yang S; Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Middle Zhi-jiang Road, Shanghai, 200071, People's Republic of China. caddie_.
Pokaż więcej
Źródło:
European radiology experimental [Eur Radiol Exp] 2024 Mar 12; Vol. 8 (1), pp. 43. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/drug therapy
Bufanolides*
Humans ; Animals ; Mice ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Mice, Nude
Czasopismo naukowe
Tytuł:
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
Autorzy:
Zhang L; Department of Urology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.; Department of Urology, Changzhou Second People's Hospital, Changzhou Medical Center, Nanjing Medical University, Nanjing, China.
Shi X; Department of Urology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
Zhang L; Department of Urology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
Mi Y; Department of Urology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Zuo L; Department of Urology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China. .
Gao S; Department of Urology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China. .; Department of Urology, Changzhou Second People's Hospital, Changzhou Medical Center, Nanjing Medical University, Nanjing, China. .; Department of Urology, Gonghe County Hospital of Traditional Chinese Medicine, Hainan Tibetan Autonomous Prefecture, Qinghai, Province, China. .
Pokaż więcej
Źródło:
Cell death & disease [Cell Death Dis] 2024 Mar 11; Vol. 15 (3), pp. 204. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Signal Transduction*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Mice ; Animals ; Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Mice, Nude ; Urinary Bladder/metabolism ; Cell Proliferation ; Apoptosis ; Adenosine Triphosphate/pharmacology ; Cell Line, Tumor ; Mammals ; Mitochondrial Precursor Protein Import Complex Proteins
Czasopismo naukowe
Tytuł:
Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma.
Autorzy:
Chen Y; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China; National Clinical Research Center for Interventional Medicine, Shanghai 200032, China.
Lei Y; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China.
Li J; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China.
Wang X; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China; National Clinical Research Center for Interventional Medicine, Shanghai 200032, China.
Li G; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China; National Clinical Research Center for Interventional Medicine, Shanghai 200032, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Mar 10; Vol. 129, pp. 111590. Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Pancreatic Neoplasms*/genetics
Carcinoma, Pancreatic Ductal*/genetics
Humans ; Animals ; Mice ; Mice, Nude ; Macrophages ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Mammalian enabled protein enhances tamoxifen sensitivity of the hormone receptor-positive breast cancer patients by suppressing the AKT signaling pathway.
Autorzy:
He L; Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China. .; Laboratory for Breast Cancer Diagnosis and Treatment of Shantou University Medical College, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China. .
She C; The Breast Center, People's Hospital of Jieyang, Jieyang, Guangdong, China. .
Jiang S; Department of Radiology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Qi Z; Laboratory for Breast Cancer Diagnosis and Treatment of Shantou University Medical College, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Deng Z; Laboratory for Breast Cancer Diagnosis and Treatment of Shantou University Medical College, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Ji L; Laboratory for Breast Cancer Diagnosis and Treatment of Shantou University Medical College, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Cui Y; Laboratory for Breast Cancer Diagnosis and Treatment of Shantou University Medical College, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Wu J; Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Pokaż więcej
Źródło:
Biology direct [Biol Direct] 2024 Mar 08; Vol. 19 (1), pp. 21. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Animals ; Female ; Humans ; Mice ; Antineoplastic Agents, Hormonal/pharmacology ; Antineoplastic Agents, Hormonal/therapeutic use ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Mammals/metabolism ; Mice, Nude ; Proto-Oncogene Proteins c-akt ; Signal Transduction ; Tamoxifen/pharmacology ; Tamoxifen/therapeutic use
Czasopismo naukowe
Tytuł:
Radiolabelled Lu-Bispidine-Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers.
Autorzy:
Cieslik PA; University of Zurich, Department of Chemistry, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Klingler S; University of Zurich, Department of Chemistry, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Nolff M; Klinik für Kleintierchirurgie, Vetsuisse-Fakultät, University of Zurich, Wintherturerstrasse 260, CH-8057, Zurich, Switzerland.
Holland JP; University of Zurich, Department of Chemistry, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Pokaż więcej
Źródło:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2024 Mar 07; Vol. 30 (14), pp. e202303805. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Radioisotopes*
Neoplasms*/diagnostic imaging
Neoplasms*/drug therapy
Receptor, ErbB-2*
Bridged Bicyclo Compounds, Heterocyclic*
Animals ; Mice ; Humans ; Female ; Trastuzumab ; Mice, Nude ; Ligands ; Cell Line, Tumor ; Lutetium
Czasopismo naukowe
Tytuł:
DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway.
Autorzy:
Xie S; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Jin Y; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Wang J; Department of Obstetrics and Gynecology, Taizhou Women and Children's Hospital of Wenzhou Medical University, 317599, Taizhou, Zhejiang, China.
Li J; Department of Obstetrics and Gynecology, Taizhou Women and Children's Hospital of Wenzhou Medical University, 317599, Taizhou, Zhejiang, China.
Peng M; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China.
Zhu X; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, 325027, Wenzhou, Zhejiang, China. .; Department of Obstetrics and Gynecology, Taizhou Women and Children's Hospital of Wenzhou Medical University, 317599, Taizhou, Zhejiang, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 04; Vol. 24 (1), pp. 296. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
MAP Kinase Signaling System*
Endometrial Neoplasms*/genetics
Animals ; Mice ; Female ; Humans ; Matrix Metalloproteinase 9 ; Mice, Nude ; Transcription Factors ; Cadherins/genetics ; Proto-Oncogene Proteins c-bcl-2 ; rac GTP-Binding Proteins
Czasopismo naukowe
Tytuł:
Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis.
Autorzy:
Zhang Z; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; BGI College, Zhengzhou University, Zhengzhou, China.
Zhao Q; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, China.
Wang Z; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; BGI College, Zhengzhou University, Zhengzhou, China.
Xu F; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, China.
Liu Y; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, China.
Guo Y; BGI College, Zhengzhou University, Zhengzhou, China.
Li C; School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
Liu T; BGI College, Zhengzhou University, Zhengzhou, China.
Zhao Y; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Tang X; Department of Veterinary Biomedical Sciences, College of Veterinary Medicine, Long Island University, Brookville, New York, USA.; Department of Medicine, Division of Regenerative Medicine, School of Medicine, Loma Linda University, Loma Linda, California, USA.; Department of Basic Science, School of Medicine, Loma Linda University, Loma Linda, California, USA.
Zhang J; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, China.; Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, China.
Pokaż więcej
Źródło:
Hepatology communications [Hepatol Commun] 2024 Mar 04; Vol. 8 (3). Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Humans ; Animals ; Mice ; Mice, Nude ; NAD ; Reactive Oxygen Species ; Ubiquinone ; Homeostasis ; Oxidoreductases
Czasopismo naukowe
Tytuł:
Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific Zr-Labeled Natalizumab Immuno-Positron Emission Tomography.
Autorzy:
Kim M; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, Korea.
Jung KH; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, Korea.
Kim JL; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Koo HJ; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Jung HJ; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Lee H; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Lee KH; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, Korea.
Pokaż więcej
Źródło:
Molecular pharmaceutics [Mol Pharm] 2024 Mar 04; Vol. 21 (3), pp. 1353-1363. Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:
Journal Article
MeSH Terms:
Integrin alpha4beta1*
Leukemia*
Humans ; Animals ; Mice ; Natalizumab/therapeutic use ; Cysteine ; Integrin alpha4 ; Mice, Nude ; Tissue Distribution ; Cell Line, Tumor ; Positron-Emission Tomography/methods ; Zirconium/chemistry
Czasopismo naukowe
Tytuł:
Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway.
Autorzy:
Zou L; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523808, China.
Li X; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523808, China.; Department of Pharmacy, People's Hospital of Longhua District, Shenzhen, Guangdong 518109, China.
Lin J; Department of Physiology, College of Basic Medical Sciences, Guangdong Medical University, Dongguan, Guangdong 523808, China.
Fang X; Department of Pharmacy, Longgang District Maternity and Child Healthcare Hospital of Shenzhen City, Shenzhen, Guangdong 518172, China.
Lin J; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523808, China.
Zhang L; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
Zhang Y; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523808, China.
Liang Y; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
Ren J; Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong SAR 999077, China.; Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, Guangdong 518108, China.
Liu Y; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
Huang Z; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523808, China.
Pokaż więcej
Źródło:
The Journal of pharmacy and pharmacology [J Pharm Pharmacol] 2024 Mar 04; Vol. 76 (3), pp. 269-282.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/metabolism
Mice ; Animals ; Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Mice, Nude ; Molecular Docking Simulation ; Cell Proliferation ; Signal Transduction ; TOR Serine-Threonine Kinases/metabolism ; Acetates/pharmacology ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the PI3K/Akt pathway through targeted inhibition of TPX2 in endometrial cancer.
Autorzy:
Yang M; Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei, University of Arts and Science, Xiangyang, China.; Institute of Maternity Disease, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Mao X; Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei, University of Arts and Science, Xiangyang, China.
Li L; Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei, University of Arts and Science, Xiangyang, China.
Yang J; Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei, University of Arts and Science, Xiangyang, China.
Xing H; Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei, University of Arts and Science, Xiangyang, China.; Institute of Maternity Disease, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Jiang C; Institute of Maternity Disease, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.; Department of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e6958.
Typ publikacji:
Journal Article
MeSH Terms:
Chemokine CXCL10*
Endometrial Neoplasms*/genetics
Animals ; Mice ; Female ; Humans ; Phosphatidylinositol 3-Kinases ; Proto-Oncogene Proteins c-akt ; Mice, Nude ; CX3C Chemokine Receptor 1 ; Microtubule-Associated Proteins/genetics ; Cell Cycle Proteins/genetics
Czasopismo naukowe
Tytuł:
The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
Autorzy:
Xiong W; Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.; Department of Head and Neck Tumour Radiotherapy, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
Li D; Department of Head and Neck Tumour Radiotherapy, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
Ao F; Department of Head and Neck Tumour Radiotherapy, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
Tu Z; Department of Head and Neck Tumour Radiotherapy, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
Xiong J; Department of Oncology, the 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Pokaż więcej
Źródło:
Cell biochemistry and function [Cell Biochem Funct] 2024 Mar; Vol. 42 (2), pp. e3939.
Typ publikacji:
Journal Article
MeSH Terms:
Proto-Oncogene Proteins c-akt*/metabolism
Nasopharyngeal Neoplasms*/genetics
Nasopharyngeal Neoplasms*/metabolism
Peptide Fragments*
Receptors, Platelet-Derived Growth Factor*
Animals ; Mice ; Humans ; Nasopharyngeal Carcinoma/genetics ; Nasopharyngeal Carcinoma/metabolism ; Nasopharyngeal Carcinoma/pathology ; Phosphatidylinositol 3-Kinases/metabolism ; NF-kappa B ; Mice, Nude ; Cell Line, Tumor ; Apoptosis/genetics ; Cell Proliferation/genetics ; Cell Movement/genetics
Czasopismo naukowe
Tytuł:
Dermal papilla cells cultured as spheres improve angiogenesis.
Autorzy:
Oppenheimer FM; Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET - Fundación Pablo Cassará), Ciudad de Buenos Aires, Argentina.
Proietti CJ; Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET - Fundación Pablo Cassará), Ciudad de Buenos Aires, Argentina.
Ceruti JM; Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET - Fundación Pablo Cassará), Ciudad de Buenos Aires, Argentina.
Hagelin K; Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET - Fundación Pablo Cassará), Ciudad de Buenos Aires, Argentina.
Leirós GJ; Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET - Fundación Pablo Cassará), Ciudad de Buenos Aires, Argentina.; Instituto de Investigación en Medicina y Ciencias de la Salud, Universidad del Salvador, Ciudad de Buenos Aires, Argentina.
Balañá ME; Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET - Fundación Pablo Cassará), Ciudad de Buenos Aires, Argentina.
Pokaż więcej
Źródło:
Experimental dermatology [Exp Dermatol] 2024 Mar; Vol. 33 (3), pp. e15038.
Typ publikacji:
Journal Article
MeSH Terms:
Angiogenesis*
Extracellular Matrix*
Animals ; Mice ; Mice, Nude ; Inflammation ; Neovascularization, Pathologic
Czasopismo naukowe
Tytuł:
Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression.
Autorzy:
Tong L; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zheng X; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wang T; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Gu W; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Shen T; Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yuan W; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wang S; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xing S; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Liu X; College of Life Sciences of Anhui Medical University, Hefei, China.
Zhang C; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhang C; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Mar; Vol. 28 (6), pp. e18164.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Animals ; Humans ; Mice ; Autophagy/genetics ; Carcinogenesis/genetics ; Cell Transformation, Neoplastic ; Membrane Proteins ; Mice, Nude
Czasopismo naukowe
Tytuł:
Fine particulate matter (PM 2.5 ) induces the stem cell-like properties of hepatocellular carcinoma by activating ROS/Nrf2/Keap1-mediated autophagy.
Autorzy:
Li J; Hefei Center for Disease Control and Prevention, Hefei 230032, China.
Jiang H; School of Public Health, Anhui Medical University, Hefei 230032, China.
Zhu Y; Hefei Center for Disease Control and Prevention, Hefei 230032, China.
Ma Z; Hefei Center for Disease Control and Prevention, Hefei 230032, China.
Li B; School of Public Health, Anhui Medical University, Hefei 230032, China.
Dong J; Hefei Center for Disease Control and Prevention, Hefei 230032, China.
Xiao C; Hefei Center for Disease Control and Prevention, Hefei 230032, China. Electronic address: .
Hu A; School of Public Health, Anhui Medical University, Hefei 230032, China. Electronic address: .
Pokaż więcej
Źródło:
Ecotoxicology and environmental safety [Ecotoxicol Environ Saf] 2024 Mar 01; Vol. 272, pp. 116052. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/genetics
Animals ; Mice ; Male ; Particulate Matter/toxicity ; Reactive Oxygen Species/metabolism ; Kelch-Like ECH-Associated Protein 1/genetics ; Kelch-Like ECH-Associated Protein 1/metabolism ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Mice, Nude ; Stem Cells/pathology ; Autophagy
Czasopismo naukowe
Tytuł:
Biomimetic biphasic microsphere preparation based on the thermodynamic incompatibility of glycosaminoglycan with gelatin methacrylate for hair regeneration.
Autorzy:
Chen Y; Department of Plastic and Aesthetic Surgery, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Fu D; Department of Plastic and Aesthetic Surgery, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Wu X; Department of Urology and Andrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China.
Zhang Y; Department of Plastic and Aesthetic Surgery, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Chen Y; Department of Plastic and Aesthetic Surgery, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Zhou Y; Department of Plastic and Aesthetic Surgery, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Lu M; Department of Urology and Andrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China. Electronic address: .
Liu Q; Department of Plastic and Aesthetic Surgery, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China. Electronic address: .
Huang J; Department of Plastic and Aesthetic Surgery, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2024 Mar; Vol. 261 (Pt 2), pp. 129934. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Gelatin*/metabolism
Glycosaminoglycans*/metabolism
Mice ; Animals ; Microspheres ; Methacrylates ; Mice, Nude ; Biomimetics ; Hair ; Hair Follicle ; Thermodynamics
Czasopismo naukowe
Tytuł:
Ononin promotes radiosensitivity in lung cancer by inhibiting HIF-1α/VEGF pathway.
Autorzy:
Zhang YM; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Miao ZM; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Chen YP; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Song ZB; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Li YY; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Liu ZW; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Zhou GC; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Li J; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Shi LL; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Chen Y; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Zhang SZ; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China.
Xu X; Department of Genetics and Cell Biology, Basic Medical College, Qingdao University, PR China.
He JP; Key Laboratory of Space Radiobiology of Gansu Province & Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, PR China.
Wang JF; Key Laboratory of Space Radiobiology of Gansu Province & Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, PR China.
Zhang LY; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China. Electronic address: .
Liu YQ; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese, Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, PR China. Electronic address: .
Pokaż więcej
Źródło:
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2024 Mar; Vol. 125, pp. 155290. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/radiotherapy
Radiation-Sensitizing Agents*/pharmacology
Glucosides*
Isoflavones*
Mice ; Animals ; Vascular Endothelial Growth Factor A/metabolism ; Mice, Nude ; Cell Line, Tumor ; Mice, Inbred C57BL ; Vascular Endothelial Growth Factors/metabolism ; Radiation Tolerance ; Hypoxia-Inducible Factor 1 ; Hypoxia-Inducible Factor 1, alpha Subunit
Czasopismo naukowe
Tytuł:
Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis.
Autorzy:
Humbert P; INSERM, UMR 1238, Phy-OS, Bone Sarcoma and Remodeling of Calcified Tissues, School of Medicine, University of Nantes, Nantes, France; INSERM, UMR 1229, RMeS, Regenerative Medicine and Skeleton, University of Nantes, Oniris, CHU Nantes, Nantes, France.
Kampleitner C; Karl Donath Laboratory for Hard Tissue and Biomaterial Research, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria; Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria; Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation With AUVA, Vienna, Austria; Austrian Cluster of Tissue Regeneration, Vienna, Austria.
De Lima J; INSERM, UMR 1238, Phy-OS, Bone Sarcoma and Remodeling of Calcified Tissues, School of Medicine, University of Nantes, Nantes, France; INSERM, UMR 1229, RMeS, Regenerative Medicine and Skeleton, University of Nantes, Oniris, CHU Nantes, Nantes, France.
Brennan MÁ; Regenerative Medicine Institute, School of Medicine and Biomedical Engineering, School of Engineering, University of Galway, Galway, Ireland.
Lodoso-Torrecilla I; Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain; Research Centre in Multiscale Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain.
Sadowska JM; Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain; Research Centre in Multiscale Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain.
Blanchard F; INSERM, UMR 1238, Phy-OS, Bone Sarcoma and Remodeling of Calcified Tissues, School of Medicine, University of Nantes, Nantes, France; INSERM, UMR 1229, RMeS, Regenerative Medicine and Skeleton, University of Nantes, Oniris, CHU Nantes, Nantes, France.
Canal C; Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain; Research Centre in Multiscale Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain.
Ginebra MP; Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain; Research Centre in Multiscale Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain; Institute of Bioengineering of Catalonia, Barcelona Institute of Science and Technology, Barcelona, Spain.
Hoffmann O; Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
Layrolle P; INSERM, UMR 1238, Phy-OS, Bone Sarcoma and Remodeling of Calcified Tissues, School of Medicine, University of Nantes, Nantes, France; INSERM, UMR 1214, ToNIC, CHU Purpan, Université Paul Sabatier, Toulouse, France. Electronic address: .
Pokaż więcej
Źródło:
Acta biomaterialia [Acta Biomater] 2024 Mar 01; Vol. 176, pp. 417-431. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Osteogenesis*
Calcium Phosphates*/pharmacology
Animals ; Humans ; Mice ; Mice, Nude ; Biocompatible Materials/pharmacology ; Durapatite/pharmacology ; Hydroxyapatites/pharmacology ; Ceramics
Czasopismo naukowe
Tytuł:
Chitosan-coated magnetic graphene oxide for targeted delivery of doxorubicin as a nanomedicine approach to treat glioblastoma.
Autorzy:
Dash BS; Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 33302, Taiwan.
Lu YJ; Department of Neurosurgery, Chang Gung Memorial Hospital, Linkou, Kwei-San, Taoyuan 33305, Taiwan.
Huang YS; Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 33302, Taiwan.
Chen JP; Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 33302, Taiwan; Department of Neurosurgery, Chang Gung Memorial Hospital, Linkou, Kwei-San, Taoyuan 33305, Taiwan; Craniofacial Research Center, Chang Gung Memorial Hospital, Linkou, Kwei-San, Taoyuan 33305, Taiwan; Research Center for Food and Cosmetic Safety, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33302, Taiwan; Department of Materials Engineering, Ming Chi University of Technology, Tai-Shan, New Taipei City 24301, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2024 Mar; Vol. 260 (Pt 1), pp. 129401. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/drug therapy
Chitosan*
Antineoplastic Agents*/pharmacology
Graphite*
Mice ; Animals ; Nanomedicine ; Mice, Nude ; Magnesium Oxide ; Doxorubicin/pharmacology ; Drug Delivery Systems/methods ; Magnetic Phenomena ; Cell Line, Tumor
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies